Coeptis Therapeutics News

10-Q: Quarterly report

Futu NewsMay 10 16:05 ET · Announcements

Coeptis Therapeutics To Present Universal Allogeneic SNAP-CAR NK Cell Therapy At ISCT 2024 From May 28 To June 1

Coeptis Therapeutics To Present Universal Allogeneic SNAP-CAR NK Cell Therapy At ISCT 2024 From May 28 To June 1

BenzingaMay 8 08:56 ET

Coeptis Therapeutics to Present Its Universal Allogeneic SNAP-CAR NK Cell Therapy at the ISCT 2024

WEXFORD, Pa., May 8, 2024 /PRNewswire/ -- Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP) (the "Company" or "Coeptis"), a biopharmaceutical company developing innovative cell therapy platforms for

Coeptis TherapeuticsMay 8 00:00 ET

Express News | Coeptis Therapeutics Announces Poster Data Presentation at American Society of Gene & Cell Therapy (Asgct) 27TH Annual Meeting

ReutersMay 2 08:47 ET

Coeptis Therapeutics Announces Poster Data Presentation at American Society of Gene & Cell Therapy (ASGCT) 27th Annual Meeting

WEXFORD, Pa., May 2, 2024 /PRNewswire/ -- Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP) (the "Company" or "Coeptis"), a biopharmaceutical company developing innovative cell therapy platforms for

Coeptis TherapeuticsMay 2 00:00 ET

Coeptis Therapeutics Congratulates Alexander Deiters, Professor at the University of Pittsburgh, on Receiving the 2024 Chancellor's Distinguished Research Award

WEXFORD, Pa., April 2, 2024 /PRNewswire/ -- Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP) ("Coeptis" or "the Company"), a biopharmaceutical company developing innovative cell therapy platforms fo

Coeptis TherapeuticsApr 2 00:00 ET

12 Health Care Stocks Moving In Tuesday's After-Market Session

GainersApollomics (NASDAQ:APLM) stock rose 10.9% to $0.61 during Tuesday's after-market session. The market value of their outstanding shares is at $54.5 million. Cara Therapeutics (NASDAQ:CARA) share

BenzingaMar 26 17:32 ET

Coeptis Expands License for CAR Technology to Autoimmune Diseases

Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP), a biopharmaceutical company, announced today an expansion of its exclusive license agreement with the University of Pittsburgh.

Investing.com Feb 26 10:40 ET

Express News | Coeptis Therapeutics Adds Autoimmune Indications To Exclusive License Agreement With University Of Pittsburgh For SNAP-CAR T And SNAP-CAR NK

Moomoo 24/7Feb 26 09:02 ET

Coeptis Therapeutics Adds Autoimmune Indications to Exclusive License Agreement With University of Pittsburgh for SNAP-CAR T and SNAP-CAR NK

Exclusive rights to universal CAR technology platform designed to target multiple antigens simultaneously, recently expanded to include SNAP-CAR NK cells, has potential to impact various autoimmune di

Coeptis TherapeuticsFeb 26 00:00 ET

Biotech With Potential: Coeptis Therapeutics (COEP) And 3 Underrated Gems

Globe PR WireFeb 21 17:43 ET

12 Health Care Stocks Moving In Monday's After-Market Session

GainersBioSig Technologies (NASDAQ:BSGM) stock increased by 7.7% to $0.96 during Monday's after-market session. The company's market cap stands at $8.9 million. Coeptis Therapeutics (NASDAQ:COEP) shar

BenzingaFeb 12 16:30 ET

12 Health Care Stocks Moving In Thursday's After-Market Session

GainersXilio Therapeutics (NASDAQ:XLO) shares rose 10.5% to $0.66 during Thursday's after-market session. The market value of their outstanding shares is at $18.2 million. Sensus Healthcare (NASDAQ:SR

BenzingaFeb 8 16:31 ET

Express News | Coeptis Therapeutics Plans To Pursue DVX201, Its Proprietary Allogeneic Stem Cell Expansion And Directed Differentiation Platform Of Unmodified Natural Killer Cell Therapy, As An Antiviral Treatment Addressing Various Respiratory Viral Infections

Moomoo 24/7Feb 7 07:40 ET

Collective Audience And 3 Other Stocks Under $1 Insiders Are Buying

The Dow Jones index closed lower by around 100 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and trader

BenzingaJan 18 08:54 ET

12 Health Care Stocks Moving In Wednesday's After-Market Session

GainersTalphera (NASDAQ:TLPH) stock moved upwards by 10.5% to $0.85 during Wednesday's after-market session. The company's market cap stands at $14.4 million. Windtree Therapeutics (NASDAQ:WINT) share

BenzingaJan 17 16:31 ET

Coeptis Therapeutics(COEP.US) Officer Buys US$3,350 in Common Stocks

$Coeptis Therapeutics(COEP.US)$ Officer Cogley Brian purchased 5,000 shares of Common Stocks on Jan 10, 2024 at an average price of $0.67 for a total value of $3,350.Source: Announcement(one of the fo

moomoo NewsJan 17 16:19 ET

Coeptis Therapeutics(COEP.US) Director Buys US$1,304.96 in Common Stocks

$Coeptis Therapeutics(COEP.US)$ Director DeSilva Tara purchased 2,266 shares of Common Stocks on Jan 12, 2024 at an average price of $0.58 for a total value of $1,304.96.Source: Announcement What is s

moomoo NewsJan 16 20:27 ET

Coeptis Therapeutics(COEP.US) Officer Buys US$7,486.5 in Common Stocks

$Coeptis Therapeutics(COEP.US)$ Officer Yerace Daniel Alexander purchased 10,850 shares of Common Stocks on Jan 5, 2024 at an average price of $0.69 for a total value of $7,486.5.Source: Announcement

moomoo NewsJan 9 17:47 ET

Coeptis Therapeutics(COEP.US) Director Buys US$8,004 in Common Stocks

$Coeptis Therapeutics(COEP.US)$ Director Salkind Gene purchased 11,600 shares of Common Stocks on Jan 5, 2024 at an average price of $0.69 for a total value of $8,004.Source: Announcement What is stat

moomoo NewsJan 9 17:47 ET